PPT-What do we know about cardiovascular disease spending and outcomes in the United States?
Author : cohen | Published Date : 2024-09-06
Source Kaiser Family Foundation analysis of 2013 OECD data OECD Health Data Health status Health status indicators OECD Health Statistics database Accessed
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "What do we know about cardiovascular dis..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
What do we know about cardiovascular disease spending and outcomes in the United States?: Transcript
Source Kaiser Family Foundation analysis of 2013 OECD data OECD Health Data Health status Health status indicators OECD Health Statistics database Accessed on July 22 2016 Notes. By: Jeremy Clark, Megan Windland, and Tiana Nater. Negative Effects of Cardiovascular disease. Eating foods that are high in saturated fats and cholesterol may cause plaque to form on artery walls. . Gary Michael Idelchik, MD, FACC. April 15, . 2015. Disclosures. I have nothing to disclose.. Outline. What is/are. … . What is Cardiovascular Disease and its manifestations?. What is Coronary Artery Disease (. FDA-Mandated CV Safety Trials. 1. TECOS. (Trial Evaluating Cardiovascular Outcomes with Sitagliptin). Clinical Outcomes with Antihyperglycemic Agents. 2. Clinical Outcomes with Sitagliptin. Study Design. Surveillance . 2016. Division . of STD Prevention . STDs in Women and Infants. Pelvic Inflammatory Disease — Initial Visits to Physicians’. Offices Among Women Aged 15–44 Years, United States, 2006–2015. Allan Coukell. Senior Director, Health Programs. The Pew Charitable Trusts. Why are pharmaceuticals an issue?. Rising prescription drug costs. Up 8.4% in 2015 ($310B). 16.7% of total health spend. Specialty drugs are key driver. Toni . Mustahsani. . Aprami. , dr., . Sp.PD. , Sp.JP. Department of Cardiology and Vascular Medicine. Cardiovascular Subdivision, Department of Internal Medicine. Hasan. . Sadikin. Hospital/Medical School, . CVOTs. 1. FDA CVOT Guidance—2008. Timeline of Major Diabetes. Outcomes Trials. 2. Blue. = Intensive vs standard control using same set of glucose-lowering agent(s). Purple. = Intensive control with a specific agent vs standard care. This brochure is designed to help public health program planners community Introduce clinical decision-support systems within healthcare systems to implement clinical guidelines at the point of care R Source. : . Kaiser Family Foundation analysis of 2013 OECD data: "OECD Health Data: Health status: Health status indicators", OECD Health Statistics (database). . doi. : 10.1787/data-00540-en (Accessed on January 22, 2016). . Page 1 of 20 UnitedHealthcare Commercial Medical Policy Effective 0 6 / 01 / 2022 Proprietary Information of UnitedHealthcare. Copyright 202 2 United HealthCare Services, Inc. UnitedHealthcareComme 1 Cardiovascular Disease in Virginia Cardiovascular disease is the most common cause of acute and chronic illness globally, in the U.S. and in Virginia. Affecting the heart and blood vessels, cardio Claire S. . Duvernoy. , MD FACC. Female Specific. concerns. U.S. CVD Deaths. CVD. deaths. Salim S. Virani. Circulation. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association, Volume: 141, Issue: 9, Pages: e139-e596.. A Scientific Statement From the AHA. Definition of . Cardiovascular-Kidney-Metabolic Syndrome (CKM). A systemic disorder characterized by pathophysiologic interactions among metabolic risk factors, chronic kidney disease, and the cardiovascular system, leading to multi-organ dysfunction and a high rate of adverse cardiovascular outcomes.. publichealth.lsuhsc.edu. Background. Cigarette smoking has been associated with negative cardiovascular health outcomes . 1. . In addition, e-cigarette use can expose one to harmful chemicals when exposed to its vapor .
Download Document
Here is the link to download the presentation.
"What do we know about cardiovascular disease spending and outcomes in the United States?"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents